Experimental study of a new orally effective broad-spectrum antimyocotic agent.
D000818:Animals; D003883:Arthrodermataceae / Q000187:drug effects; D001228:Aspergillosis / Q000188:drug therapy; D002175:Candida / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy; D003045:Coccidioides / Q000187:drug effects; D003881:Dermatomycoses / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D005658:Fungi / Q000187:drug effects*; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D008864:Microsporum / Q000187:drug effects; D003904:Mitosporic Fungi / Q000187:drug effects; D009089:Mucor / Q000187:drug effects; D009615:Nocardia / Q000187:drug effects; D013175:Sporothrix / Q000187:drug effects; D014005:Tinea / Q000188:drug therapy
D007093:Imidazoles